Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenues:
Total revenues	$ 78,354	$ 66,263
Expenses:
Cost of goods sold - commercial	3,768	3,819
Research and development	11,022	10,013
Selling, general and administrative	25,014	22,329
Loss (gain) on foreign currency transaction	2,509	(1,399)
Total expenses	56,061	49,541
Income from operations	22,293	16,722
Other income (expense):
Interest income, net	1,956	3,434
Interest expense	(4,645)	(2,567)
Interest expense on liability for sale of future royalties	(3,577)	(4,248)
Interest expense on financing liability	(2,410)	(2,447)
Total other expense	(8,676)	(5,828)
Income before income tax expense	13,617	10,894
Income tax expense	459	264
Net income	$ 13,158	$ 10,630
Net income per share - basic	$ 0.04	$ 0.04
Weighted average shares used to compute net income per share - basic	303,481	270,356
Net income per share - diluted	$ 0.04	$ 0.04
Weighted average shares used to compute net income per share - diluted	320,897	324,733
Commercial product sales
Revenues:
Total revenues	$ 18,973	$ 18,764
Collaborations and services
Revenues:
Total revenues	29,376	24,848
Expenses:
Cost of revenue	13,748	14,779
Royalties
Revenues:
Total revenues	$ 30,005	$ 22,651